# Atsena Therapeutics

**Canonical:** https://apis.io/providers/atsena-therapeutics/  
**Website:** https://atsenatx.com/  
**APIs profiled:** 8

Atsena Therapeutics is a clinical-stage gene therapy company based in Durham, North Carolina, in the Research Triangle, developing first- and best-in-class genetic medicines for inherited retinal diseases with the goal of reversing or preventing blindness. Founded by ocular gene therapy pioneers Shannon Boye and Sanford Boye, the company builds on two proprietary AAV delivery platforms: a laterally spreading AAV.SPR capsid engineered to reach retinal cells without the surgical trauma of a subretinal bleb, and a dual-vector technology that splits genes too large for a single AAV across two vectors. Its clinical pipeline includes ATSN-201 for X-linked retinoschisis (XLRS) in a pivotal Phase 3 trial, ATSN-101 for LCA1 (Leber congenital amaurosis 1) advancing to a pivotal trial with partner Nippon Shinyaku, and IND-enabling programs ATSN-301 for Usher syndrome 1B and ATSN-401 for Stargardt disease. Atsena runs no developer program and publishes no product API, no developer documentation and no specification of its own. The only machine-readable surface it exposes is the anonymously readable WordPress REST content API behind atsenatx.com, which serves the company's press releases, program and platform pages, and media library as JSON; the OpenAPI in this repo is derived by API Evangelist from that surface's own live route index.

## Kin Score — 30.4 / 100 (thin)

Scored 2026-08-25 under rubric 0.14.0. Trend: flat (-0.7 from 31.1).

| Facet | Score |
|---|---|
| Discoverability | 74.1 |
| Contract Quality | 54.3 |
| Governance | 16.7 |
| Contract Governance | 16.7 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 20.8 |
| Commercial Clarity | 10.5 |
| Access Clarity | 10.5 |

Regulatory layer — **Health**: 26.3 (matched via tags).

## Agent readiness — 22.3 (agent-aware)

| Dimension | Value |
|---|---|
| Spec Presence | yes |
| Agentic Access | no |
| Reversibility Documented | na |
| MCP Server | no |
| Auth Clarity | bearer |
| Idempotency | na |
| Error Semantics | documented |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | derived |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | na |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## APIs (8)

- **Atsena Therapeutics Categories API** — Post categories
- **Atsena Therapeutics Discovery API** — Route index, content types, taxonomies and post statuses
- **Atsena Therapeutics Media API** — Media library items
- **Atsena Therapeutics O Embed API** — oEmbed representation of site URLs
- **Atsena Therapeutics Pages API** — Static site pages: programs, technology, clinical trials, patients, about
- **Atsena Therapeutics Posts API** — Press releases and company news
- **Atsena Therapeutics Search API** — Cross-content search over posts and pages
- **Atsena Therapeutics Tags API** — Post tags

## Security (2)

- **Atsena Therapeutics Authentication** — none/http/apiKey · 3 schemes
- **Atsena Therapeutics Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company, Biotechnology, Gene Therapy, Life Sciences, Pharmaceuticals, Clinical Trials, Ophthalmology, Rare Disease, Healthcare, Research and Development, content-api, WordPress

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/atsena-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.